3,4-diaminopyridine
( DrugBank: - / KEGG DRUG: - )
2 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
12 | Congenital myasthenic syndrome | 4 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
13 | Multiple sclerosis | 2 |
12. Congenital myasthenic syndrome
Clinical trials : 6 / Drugs : 4 - (DrugBank : 3) / Drug target genes : 5 - Drug target pathways : 15
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
13. Multiple sclerosis
Clinical trials : 3,685 / Drugs : 1,932 - (DrugBank : 355) / Drug target genes : 263 - Drug target pathways : 237
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|